Answer
Jun 11, 2026 - 08:23 AM
Abacavir and Lamivudine are nucleoside reverse transcriptase inhibitors (NRTIs) that block HIV’s ability to replicate its genetic material, while Dolutegravir is an integrase strand transfer inhibitor (INSTI) that prevents HIV from integrating its genetic material into human cells. Together, they provide a powerful, multi-targeted approach to suppressing HIV, which is valuable for effective long-term management of the virus.
